Xiaolan Shi

873 total citations
43 papers, 496 citations indexed

About

Xiaolan Shi is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Xiaolan Shi has authored 43 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 16 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Xiaolan Shi's work include Multiple Myeloma Research and Treatments (12 papers), CAR-T cell therapy research (8 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Xiaolan Shi is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), CAR-T cell therapy research (8 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Xiaolan Shi collaborates with scholars based in China, Hong Kong and Brunei. Xiaolan Shi's co-authors include Lingzhi Yan, Chengcheng Fu, Jingjing Shang, Long Zhao, Cuicui Liu, Liqing Kang, Song Jin, Jing Wang, Guanghua Chen and Liqun Shang and has published in prestigious journals such as Blood, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Xiaolan Shi

39 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Shi China 14 242 209 92 91 57 43 496
Sunniyat Rahman United Kingdom 12 195 0.8× 203 1.0× 59 0.6× 28 0.3× 10 0.2× 26 529
Wenli Cui China 16 148 0.6× 185 0.9× 61 0.7× 28 0.3× 17 0.3× 52 688
Mei-Hsuan Wu Taiwan 15 163 0.7× 243 1.2× 37 0.4× 31 0.3× 12 0.2× 27 676
Jingwen Wang China 13 111 0.5× 179 0.9× 84 0.9× 170 1.9× 17 0.3× 61 635
Ya‐Hsuan Chang Taiwan 16 117 0.5× 287 1.4× 66 0.7× 32 0.4× 17 0.3× 42 624
Weihua Zhang China 14 51 0.2× 129 0.6× 57 0.6× 144 1.6× 30 0.5× 53 689
Catherine Zhu United States 14 47 0.2× 241 1.2× 99 1.1× 76 0.8× 17 0.3× 23 684
Jonathan D. Diedrich United States 12 108 0.4× 156 0.7× 39 0.4× 35 0.4× 35 0.6× 19 558
Satoru Monzen Japan 14 64 0.3× 247 1.2× 59 0.6× 83 0.9× 29 0.5× 56 656
S. Lawrence Bailey United States 13 71 0.3× 170 0.8× 91 1.0× 227 2.5× 15 0.3× 37 652

Countries citing papers authored by Xiaolan Shi

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Shi more than expected).

Fields of papers citing papers by Xiaolan Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Shi. The network helps show where Xiaolan Shi may publish in the future.

Co-authorship network of co-authors of Xiaolan Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Shi. A scholar is included among the top collaborators of Xiaolan Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Shi. Xiaolan Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Chengcheng, Yingying Zhai, Lingzhi Yan, et al.. (2025). Redefining multiple myeloma treatment: Advances, challenges, and future directions in immunotherapy. Chinese Medical Journal. 138(19). 2399–2410.
2.
Zhang, Ling, Haiyan Qiu, Yang Hong, et al.. (2025). The effects of maternal health literacy, family functioning and self-efficacy on antepartum depression in pregnant women in China: a moderated mediation model. BMC Psychiatry. 25(1). 101–101. 1 indexed citations
3.
Shi, Xiaolan, et al.. (2024). Factors associated with intrinsic capacity impairment in hospitalized older adults: a latent class analysis. BMC Geriatrics. 24(1). 494–494. 8 indexed citations
4.
Deng, Guohua, Xiaolan Shi, Zhihong Liu, et al.. (2024). Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies. ESMO Open. 9(3). 102241–102241. 20 indexed citations
5.
Zhou, Shiyuan, Yingying Zhai, Lingzhi Yan, et al.. (2023). Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment. Journal of Clinical Medicine. 12(19). 6239–6239.
6.
Zhai, Yingying, Lingzhi Yan, Song Jin, et al.. (2023). Autologous stem cell transplantation in multiple myeloma patients with renal impairment. Annals of Hematology. 102(3). 621–628. 2 indexed citations
7.
8.
Wei, Lijun, Xiaoxia Zhu, Xinyu Qi, et al.. (2023). TT3, a More Practical Indicator for Evaluating the Relationship Between Sarcopenia and Thyroid Hormone in the Euthyroid Elderly Compared with FT3. Clinical Interventions in Aging. Volume 18. 1285–1293. 14 indexed citations
9.
10.
11.
Jin, Song, Qingqing Wang, Shuang Yan, et al.. (2022). The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients. Frontiers in Oncology. 12. 938392–938392. 5 indexed citations
12.
Zong, Zheng, Xiaolan Shi, Chongguo Tian, et al.. (2022). Nitrogen isotopic composition of NOx from residential biomass burning and coal combustion in North China. Environmental Pollution. 304. 119238–119238. 26 indexed citations
13.
14.
Bian, Lifang, Chao Zheng, & Xiaolan Shi. (2021). Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report. World Journal of Clinical Cases. 9(16). 4110–4115. 7 indexed citations
15.
Shang, Liqun, Li Wang, Xiaolan Shi, et al.. (2019). HMGB1 was negatively regulated by HSF1 and mediated the TLR4/MyD88/NF-κB signal pathway in asthma. Life Sciences. 241. 117120–117120. 54 indexed citations
16.
Yan, Lingzhi, Zhi Yan, Jingjing Shang, et al.. (2019). Sequential CD19- and Bcma-Specific Chimeric Antigen Receptor T Cell Treatment for RRMM: Report from a Single Center Study. Blood. 134(Supplement_1). 578–578. 16 indexed citations
17.
Yan, Lingzhi, Jingjing Shang, Liqing Kang, et al.. (2017). Combined Infusion of CD19 and Bcma-Specific Chimeric Antigen Receptor T Cells for RRMM: Initial Safety and Efficacy Report from a Clinical Pilot Study. Blood. 130. 506–506. 26 indexed citations
18.
Sui, Hua, Xuan Liu, Lihong Zhou, et al.. (2014). Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway. BMC Complementary and Alternative Medicine. 14(1). 279–279. 51 indexed citations
19.
20.
Shi, Xiaolan, Xiaowen Tang, & Depei Wu. (2011). Research progresses in the pathogenesis of anaplastic large cell lymphoma. Chinese Journal of Cancer. 30(6). 392–399. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunniyat Rahman Breakdown of academic impact, for papers by Wenli Cui Breakdown of academic impact, for papers by Mei-Hsuan Wu Breakdown of academic impact, for papers by Jingwen Wang Breakdown of academic impact, for papers by Ya‐Hsuan Chang Breakdown of academic impact, for papers by Weihua Zhang Breakdown of academic impact, for papers by Catherine Zhu Breakdown of academic impact, for papers by Jonathan D. Diedrich Breakdown of academic impact, for papers by Satoru Monzen Breakdown of academic impact, for papers by S. Lawrence Bailey
Rankless by CCL
2026